EPICRISPR BIOTECHNOLOGIES

Serial Number 98125106
606

Registration Progress

Application Filed
Aug 9, 2023
Under Examination
Feb 25, 2025
Approved for Publication
Dec 31, 2024
Published for Opposition
Dec 31, 2024
Registered

Trademark Image

EPICRISPR BIOTECHNOLOGIES

Basic Information

Serial Number
98125106
Filing Date
August 9, 2023
Published for Opposition
December 31, 2024
Abandonment Date
September 29, 2025
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 29, 2025
Classes
042

Rights Holder

Epicrispr Biotechnologies, Inc.

03
Address
Suite 100, 7000 Shoreline Court
South San Francisco, CA 94080

Ownership History

Epicrispr Biotechnologies, Inc.

Original Applicant
03
South San Francisco, CA

Epicrispr Biotechnologies, Inc.

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
Salima A. Merani, Ph.D.

USPTO Deadlines

All Deadlines Cleared

All 6 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

26 events
Date Code Type Description Documents
Sep 29, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 29, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 25, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 7, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 7, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 7, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 31, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 31, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 25, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 4, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 5, 2024 ALIE A ASSIGNED TO LIE Loading...
Nov 5, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 5, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 13, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 13, 2024 PETG O PETITION TO REVIVE-GRANTED Loading...
Aug 13, 2024 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Aug 13, 2024 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Jul 31, 2024 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Jul 31, 2024 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Apr 16, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 16, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 16, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 9, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 12, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 10, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 12, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development services, all of the foregoing in the fields of gene regulation and epigenetics and the use of CRISPR technology in relation thereto; Medical research services, namely, development of genetic medicine therapies, all of the foregoing in the fields of gene regulation and epigenetics and the use of CRISPR technology in relation thereto; provision of medical research and scientific research information in the field of gene regulation and epigenetics and the use of CRISPR technology in relation thereto

Additional Information

Design Mark
The mark consists of the term "EPICRISPR" over the term "BIOTECHNOLOGIES" with a triangle dotting each of the letter "I" in "EPICRISPR" and a cascade of dots starting over the first letter "P" and ending under the second letter "P" of "EPICRISPR".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTECHNOLOGIES"